MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

Frederik Barkhof; Jack H. Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola De Stefano; Chris H. Polman; John Petkau; Ernst W. Radue; Maria Pia Sormani; David K. Li; Paul O’Connor; Xavier Montalbán; David H. Miller; Massimo Filippi

doi:10.1038/nrneurol.2011.190

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Early red nucleus atrophy in relapse‐onset multiple sclerosis

Monica Margoni, Davide Poggiali, Sofia Zywicki, Martina Rubin, Andrea Lazzarotto, Silvia Franciotta, Maria Giulia Anglani, Francesco Causin, Francesca Rinaldi, Paola Perini, Massimo Filippi, Paolo Gallo

Article2023

Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study

Monica Margoni, Elisabetta Pagani, Paolo Preziosa, Mor Gueye, Matteo Azzimonti, Maria A. Rocca, Massimo Filippi

Article1997

Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials

Frederik Barkhof, Massimo Filippi, David H. Miller, Paul S. Tofts, Ludwig Kappos, Alan J. Thompson

Article2016

Working memory network dysfunction in relapse-onset multiple sclerosis phenotypes: A clinical-imaging evaluation

Laura Vacchi, Maria A. Rocca, Alessandro Meani, Mariaemma Rodegher, Vittorio Martinelli, Gıancarlo Comı, Andrea Falini, Massimo Filippi

Article2009

A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis

Massimiliano Calabrese, Maria A. Rocca, Matteo Atzori, I. Mattisi, Alice Favaretto, Paola Perini, Paolo Gallo, Massimo Filippi